Lee Danner & Bass Inc. Sells 9,086 Shares of National Health Investors, Inc. (NYSE:NHI)

Lee Danner & Bass Inc. lowered its position in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) by 12.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 63,431 shares of the real estate investment trust's stock after selling 9,086 shares during the period. Lee Danner & Bass Inc. owned about 0.14% of National Health Investors worth $4,685,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in NHI. Norges Bank purchased a new stake in National Health Investors in the 4th quarter valued at approximately $42,322,000. Millennium Management LLC increased its holdings in shares of National Health Investors by 1,967.0% during the 4th quarter. Millennium Management LLC now owns 488,353 shares of the real estate investment trust's stock worth $33,843,000 after buying an additional 464,727 shares during the last quarter. Balyasny Asset Management L.P. acquired a new stake in shares of National Health Investors during the 4th quarter worth $23,917,000. Marshall Wace LLP boosted its position in National Health Investors by 161.6% during the 4th quarter. Marshall Wace LLP now owns 551,585 shares of the real estate investment trust's stock worth $38,225,000 after purchasing an additional 340,712 shares during the period. Finally, Land & Buildings Investment Management LLC boosted its position in National Health Investors by 109.4% during the 4th quarter. Land & Buildings Investment Management LLC now owns 467,056 shares of the real estate investment trust's stock worth $32,367,000 after purchasing an additional 243,999 shares during the period. Institutional investors and hedge funds own 62.51% of the company's stock.

National Health Investors Price Performance

Shares of NHI stock traded up $0.06 during trading hours on Wednesday, reaching $70.34. 182,275 shares of the company were exchanged, compared to its average volume of 248,564. National Health Investors, Inc. has a fifty-two week low of $65.13 and a fifty-two week high of $86.13. The stock's fifty day moving average is $72.66 and its two-hundred day moving average is $71.61. The company has a market cap of $3.28 billion, a price-to-earnings ratio of 22.33, a P/E/G ratio of 4.25 and a beta of 0.73. The company has a debt-to-equity ratio of 0.88, a current ratio of 16.55 and a quick ratio of 16.55.

National Health Investors (NYSE:NHI - Get Free Report) last issued its earnings results on Monday, May 5th. The real estate investment trust reported $1.15 EPS for the quarter, beating the consensus estimate of $1.13 by $0.02. National Health Investors had a net margin of 41.15% and a return on equity of 10.64%. The firm had revenue of $68.87 million during the quarter, compared to the consensus estimate of $85.13 million. During the same quarter in the prior year, the firm earned $1.10 earnings per share. The business's quarterly revenue was up 9.6% on a year-over-year basis. Sell-side analysts forecast that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Monday, June 30th will be issued a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 5.12%. The ex-dividend date is Monday, June 30th. National Health Investors's payout ratio is 114.29%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on NHI shares. Truist Financial raised shares of National Health Investors from a "hold" rating to a "buy" rating and set a $77.00 price target on the stock in a research report on Wednesday, July 2nd. Wedbush raised National Health Investors to a "strong-buy" rating in a report on Wednesday, July 2nd. Two analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $85.75.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.